SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Impath Inc. (IMPH) -- Ignore unavailable to you. Want to Upgrade?


To: Zachary Wentworth who wrote (61)2/12/1999 3:04:00 PM
From: scott  Read Replies (3) | Respond to of 68
 
Thread: IMPH is listed by S&P as a "Power Pick" for 1999. A good business model, great growth story, etc, etc. BUT!!!!, WHAT AN UGLY CHART!!!! I will be watching this one for a possible entry. Any ideas out there??? This sure is a quiet thread.
Regards......



To: Zachary Wentworth who wrote (61)5/6/1999 3:39:00 PM
From: Ausdauer  Respond to of 68
 
Zach,

My ticker tape shows...

28 3/4 on 93,500 shares traded.

Ausdauer



To: Zachary Wentworth who wrote (61)9/9/1999 11:56:00 AM
From: Ausdauer  Read Replies (1) | Respond to of 68
 
Zach and Thread,

I read an interesting piece on Lance Armstrong in SI (Sports Illustrated) about his personal discussions with his oncologist that lead to his decision to have surgical excision of his brain mets (rather than radiation) and avoidance of bleomycin in his chemotherapeutic regimen (lung toxicity). No one can argue with the results of his tailored treatment.

I think IMPH's tumor/treatment database is a real jewel. If there is enthusiastic physician participation, accurate data collection & follow-up data and a continually growing log of cases this information may prove to be quite useful in the future to those planning research trials or accessing the database for treatment options. This data could prove valuable in its own right and may also attract new clients to the core diagnostics lab.

Anybody know about forces behind the recent movement in the stock?

Ausdauer